How old is patient?
advertisement

Here is the some steps to help you to save money on 24 HR TNG 0.2 MG/HR Transdermal Patch purchase.


Read drug prescription


What is 24 HR TNG 0.2 MG/HR Transdermal Patch

24 HR TNG 0.2 MG/HR Transdermal Patch is in a group of drugs called nitrates. 24 HR TNG 0.2 MG/HR Transdermal Patch dilates blood vessels, making it easier for blood to flow through them and easier for the heart to pump.
24 HR TNG 0.2 MG/HR Transdermal Patch is used to treat or prevent attacks of chest pain (angina).
24 HR TNG 0.2 MG/HR Transdermal Patch may also be used for purposes not listed in 24 HR TNG 0.2 MG/HR Transdermal Patch guide.

24 HR TNG 0.2 MG/HR Transdermal Patch side effects

Get emergency medical help if you have any of these signs of an allergic reaction: hives; difficulty breathing; swelling of your face, lips, tongue, or throat.
Seek emergency medical attention if you have symptoms of a heart attack, such as:

24 HR TNG 0.2 MG/HR Transdermal Patch can cause severe headaches, especially when you first start using it. These headaches may gradually become less severe as you continue to use 24 HR TNG 0.2 MG/HR Transdermal Patch. Do not stop taking this medicine. Ask your doctor before using any headache pain medication.
Call your doctor at once if you have:

Common side effects may include:

This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
See also: Side effects (in more detail)
advertisement

24 HR TNG 0.2 MG/HR Transdermal Patch dosing

Usual Adult Dose for Angina Pectoris:

For relief of acute anginal attack:
Lingual spray: 1 to 2 sprays onto or under the tongue every 3 to 5 minutes as needed, up to 3 sprays in 15 minutes. If pain persists after the maximum number of doses, prompt medical attention is recommended.
Sublingual tablet: 0.3 to 0.6 mg dissolved under the tongue or in the 24 HR TNG 0.2 MG/HR Transdermal Patch pouch every 5 minutes as needed, up to 3 doses in 15 minutes. If pain persists after the maximum number of doses, prompt medical attention is recommended.
IV continuous infusion (via non PVC tubing): 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed, up to a usual maximum of 200 and generally no more than 400 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Angina Pectoris Prophylaxis:

Lingual spray: 1 to 2 sprays (0.4 to 0.8 mg) onto or under the tongue 5 to 10 minutes prior to engaging in activities which might precipitate an acute attack
Sublingual tablet: 0.3 to 0.6 mg dissolved under the tongue or in the 24 HR TNG 0.2 MG/HR Transdermal Patch pouch 5 to 10 minutes prior to engaging in activities which might precipitate an acute attack
Topical ointment: 1/2 inch initially, applied to a non hairy area of the trunk every 6 to 8 hours during waking hours (2 times a day); titrate as needed and tolerated. If angina occurs while the ointment is in place, the dose should be increased; if angina occurs several hours after application, the dosing frequency should be increased. Usual range is 1/2 to 2 inches (7.5 to 30 mg) every 8 hours, typically applied to 36 square inches of truncal skin.
Transdermal patch: 0.1 to 0.4 mg/hr patch applied to a dry and hairless area of the upper arm or body for 12 to 14 hours per day; titrate as needed and tolerated up to 0.8 mg/hr. Application sites should be rotated to avoid skin irritation.
Transmucosal (buccal) tablet: 1 mg dissolved between the lip and gum above the upper incisors or between the cheek and gum every 3 to 5 hours during waking hours (approximately 3 times a day); titrate as needed and tolerated. If angina occurs while a tablet is in place, the dose should be increased to the next strength; if angina occurs after dissolution of tablet, the dosing frequency should be increased. Usual maintenance dosage is 2 mg three times a day. If an acute attack occurs while a tablet is in place, another tablet may be administered on the opposite side from the one already in place. Sublingual 24 HR TNG 0.2 MG/HR Transdermal Patch is recommended if prompt relief is not attained.
Oral: 2.5 every 8 to 12 hours; titrate as needed and tolerated up to 9 mg every 8 to 12 hours
Because tolerance to 24 HR TNG 0.2 MG/HR Transdermal Patch may develop if plasma levels are maintained continuously, a nitrate free interval of 10 to 12 hours per day may be appropriate during chronic prophylaxis of angina pectoris. However, clinical studies suggest that such intermittent use may be associated with hemodynamic rebound during drug withdrawal and decreased exercise tolerance during the latter part of the nitrate free interval. Although the clinical relevance of this observation is unknown, a potentially increased risk of anginal attack during the nitrate free interval should be considered. Therefore, dosing regimens should be carefully individualized to each patient. Other antianginal drugs such as beta-blockers and calcium channel blockers may be prescribed to reduce the risk of aggravating myocardial ischemia during the drug free intervals.

Usual Adult Dose for Congestive Heart Failure:

Topical ointment: 1/2 inch initially, applied to a non hairy area of the trunk every 6 to 8 hours during waking hours ; titrate as needed and tolerated. Usual range is 1/2 to 2 inches (7.5 to 30 mg) every 8 hours, typically applied to 36 square inches of truncal skin.
Transdermal patch: 0.1 to 0.4 mg/hr patch applied to a dry and hairless area of the upper arm or body for 12 to 14 hours per day; titrate as needed and tolerated up to 0.8 mg/hr. Application sites should be rotated to avoid skin irritation.
Transmucosal (buccal) tablet: 1 mg dissolved between the lip and gum above the upper incisors or between the cheek and gum every 3 to 5 hours during waking hours (approximately 3 times a day); titrate as needed and tolerated. Usual maintenance dosage is 2 mg three times a day.
Oral: 2.5 every 8 to 12 hours; titrate as needed and tolerated up to 9 mg every 8 to 12 hours

Usual Adult Dose for Myocardial Infarction:

For the initial 24 to 48 hours after an acute myocardial infarction:
IV continuous infusion (via non PVC tubing): 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed up to a usual maximum of 200 and generally no more than 400 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Hypertension:

IV continuous infusion : 5 mcg/min initially, increased by 5 mcg/min every 3 to 5 minutes as needed up to 20 mcg/min, then gradually by 10 and then 20 mcg/min if needed up to a usual maximum of 100 mcg/min. Starting dosages of 25 mcg/min or higher have been used with PVC administration sets.

Usual Adult Dose for Anal Fissure and Fistula:

For the treatment of moderate to severe pain associated with chronic anal fissure:
Apply 1 inch of ointment (375 mg of ointment equivalent to 1.5 mg of 24 HR TNG 0.2 MG/HR Transdermal Patch) intra anally every 12 hours for up to 3 weeks.

Usual Pediatric Dose for Hypertension:

Perioperative hypertension or induction of intraoperative hypotension:
IV continuous infusion: 0.25 to 0.5 mcg/kg/min initially, increase by 0.5 to 1 mcg/kg/min every 3 to 5 minutes as needed up to 5 mcg/kg/min. Usual dose is 1 to 3 mcg/kg/min, but doses as high as 20 mcg/kg/min have been used.

Select the most affordable brand or generic drug


StrengthQuantityPrice, USDCountry
GTN 0.4mg Spray $4.19Medley Pharmaceuticals
GTN 0.4MG SPRAY 1 packet(s) (200 MDI spray each) $4.19Medley Pharmaceuticals
GTN 2.6mg Tablet $0.07Abbott India Ltd
GTN 6.4mg Tablet $0.08Abbott India Ltd
MYONIT SR 2.6 MG TABLET 1 strip(s) (30 tablets each) $2.09Troikaa Pharmaceuticals Ltd
MYONIT Injection / 5mg per ml (5ml units) $0.63Troikaa Pharmaceuticals
Myonit 6.4mg Tablet CR $0.10Troikaa Pharmaceuticals Ltd
Myonit 5mg x 1mL AMP / 10ml $1.12
0 .4mg100 $54.59Australia, Canada, India, NZ, Singapore, Turkey, UK, USA
0 .4mg100 $56.32Australia, Canada, India, Mauritius, NZ, Turkey, Singapore, UK, USA
NITROWOK tab 2.6 mg x 30's $1.54Wockhardt (Cardio)
NITROWOK 2.6 MG TABLET 1 strip(s) (30 tablets each) $1.55Wockhardt Ltd
NITROWOK tab 6.4 mg x 30's $1.89Wockhardt (Cardio)
advertisement

References

  1. Dailymed."Nitroglycerin: dailymed provides trustworthy information about marketed drugs in the united states. dailymed is the official provider of fda label information (package inserts).". https://dailymed.nlm.nih.gov/dailym... (accessed August 28, 2018).
  2. "Nitroglycerin". https://pubchem.ncbi.nlm.nih.gov/co... (accessed August 28, 2018).
  3. "Nitroglycerin". http://www.drugbank.ca/drugs/DB0072... (accessed August 28, 2018).

24 HR TNG 0.2 MG/HR Transdermal Patch - Frequently asked Questions

Can 24 HR TNG 0.2 MG/HR Transdermal Patch be stopped immediately or do I have to stop the consumption gradually to ween off?

In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.

It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.

How should I take 24 HR TNG 0.2 MG/HR Transdermal Patch?

Follow all directions on your prescription label. Do not take this medicine in larger or smaller amounts or for longer than recommended. Keep this medicine on hand at all times in case of an angina attack. Get your prescription refilled before you run out of medicine completely.

24 HR TNG 0.2 MG/HR Transdermal Patch is usually taken at the first sign of chest pain. If possible, try to rest or stay seated when you use this medication. 24 HR TNG 0.2 MG/HR Transdermal Patch can cause dizziness or fainting.

You may use 24 HR TNG 0.2 MG/HR Transdermal Patch sublingual within 5 to 10 minutes before an activity you think might cause chest pain. Follow your doctor's instructions.

If you use 24 HR TNG 0.2 MG/HR Transdermal Patch sublingual spray to treat an angina attack: At the first sign of an attack, apply the spray directly on or under your tongue. Close your mouth after each spray. Do not inhale the spray. Do not shake the spray before or during use. You may use additional sprays every 5 minutes, but not more than 3 sprays in 15 minutes.

The 24 HR TNG 0.2 MG/HR Transdermal Patch sublingual tablet should be placed under your tongue and allowed to dissolve slowly. Do not chew or swallow it. You may use additional tablets every 5 minutes, but not more than 3 tablets in 15 minutes.

Seek emergency medical attention if your chest pain gets worse or lasts more than 5 minutes, especially if you have trouble breathing or feel weak, dizzy, or nauseated, or lightheaded.

You may feel a slight burning or stinging in your mouth when you use this medicine. However, this sensation is not a sign of how well the medication is working. Do not use more medication just because you do not feel a burning or stinging.

Do not crush, chew, break, or open an extended-release capsule. Swallow it whole.

This medicine can cause unusual results with certain medical tests. Tell any doctor who treats you that you are using 24 HR TNG 0.2 MG/HR Transdermal Patch.

If you take 24 HR TNG 0.2 MG/HR Transdermal Patch on a regular schedule to prevent angina, do not stop taking it suddenly or you could have a severe attack of angina.

Store the tablets in the glass container at room temperature, away from moisture and heat. Keep the bottle tightly closed when not in use.

Keep the spray away from open flame or high heat, such as in a car on a hot day. The canister may explode if it gets too hot.

Who should not take 24 HR TNG 0.2 MG/HR Transdermal Patch?

You should not use 24 HR TNG 0.2 MG/HR Transdermal Patch if you are allergic to it, or if:

Do not take erectile dysfunction medicine (Viagra, Cialis, Levitra, Stendra, Staxyn, sildenafil, avanafil, tadalafil, vardenafil) while you are taking 24 HR TNG 0.2 MG/HR Transdermal Patch. Using erectile dysfunction medicine with 24 HR TNG 0.2 MG/HR Transdermal Patch can cause a sudden and serious decrease in blood pressure.

You should not use sublingual 24 HR TNG 0.2 MG/HR Transdermal Patch if you have:

To make sure 24 HR TNG 0.2 MG/HR Transdermal Patch is safe for you, tell your doctor if you have:

FDA pregnancy category C. It is not known whether 24 HR TNG 0.2 MG/HR Transdermal Patch will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.

It is not known whether 24 HR TNG 0.2 MG/HR Transdermal Patch passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.

What other drugs will affect 24 HR TNG 0.2 MG/HR Transdermal Patch?

Many drugs can interact with 24 HR TNG 0.2 MG/HR Transdermal Patch. Not all possible interactions are listed here. Tell your doctor about all your medications and any you start or stop using during treatment with 24 HR TNG 0.2 MG/HR Transdermal Patch, especially:

This list is not complete and many other drugs can interact with 24 HR TNG 0.2 MG/HR Transdermal Patch. This includes prescription and over-the-counter medicines, vitamins, and herbal products. Give a list of all your medicines to any healthcare provider who treats you.

Can 24 HR TNG 0.2 MG/HR Transdermal Patch be taken or consumed while pregnant?

Please visit your doctor for a recommendation as such case requires special attention.

Can 24 HR TNG 0.2 MG/HR Transdermal Patch be taken for nursing mothers or during breastfeeding?

Kindly explain your state and condition to your doctor and seek medical advice from an expert.

advertisement

Reviews

Following the study conducted by gmedication.com on 24 HR TNG 0.2 MG/HR Transdermal Patch, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of 24 HR TNG 0.2 MG/HR Transdermal Patch. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.

Patient reports

Patient reported useful

No survey data has been collected yet


Patient reported side effects

No survey data has been collected yet


Patient reported price estimates

No survey data has been collected yet


Patient reported frequency of use

No survey data has been collected yet


Patient reported doses

No survey data has been collected yet


Patient reported time for results

No survey data has been collected yet


Patient reported administration

No survey data has been collected yet


Patient reported age

No survey data has been collected yet


Patient reviews


There are no reviews yet. Be the first to write one!


Your name: 
Email: 
Spam protection:  < Type 28 here

The information was verified by Dr. Vishal Pawar, MD Pharmacology